Losartan Potassium
Product Images NDC 53808-1043

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53808-1043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 100mg (Losartan Potassium 100mg)

Losartan Potassium is a medication available in 100 mg tablets. The manufacturer is Torrent and the product code is 061 Lo ecsmania. The pharmacy from which the product has been obtained is PK36Y DOH Carr Pharmacy in Tallahassee, Florida. The UPC number for the product is 313668115307.*

FDA Label Image

Label Image For 50mg (Losartan Potassium 50mg)

LOSARTAN POTASSIUM 50MG TABS is a prescription medication packaged by DOH Central Pharmacy with an expiration date of January 31, 2014. The medication is in a lot number labeled B0502007 by Torrent Pharmaceuticals. However, the text at the end of the description is not available as it contains non-English characters.*

FDA Label Image

Structural Formula (Losartanpotassiumusp Figure 01)

FDA Label Image

Image (Losartanpotassiumusp Figure 02)

FDA Label Image

Image (Losartanpotassiumusp Figure 03)

This text shows a comparison between the effectiveness of Atenolol and Losartan Potassium Tablets in reducing the risk of fatal and non-fatal stroke in patients. According to the data presented, Losartan Potassium Tablets were found to have a 25% adjusted risk reduction in strokes compared to Atenolol, and this difference was statistically significant (p=0.001). The chart shows the study period in months.*

FDA Label Image

Image (Losartanpotassiumusp Figure 04)

FDA Label Image

Image (Losartanpotassiumusp Figure 05)

Losartan Potassium Tablets showed a risk reduction of 16.1% compared to Placebo in patients over a period of several months, as indicated by a statistically significant p-value of 0.022. Data on the percentage of patients is also provided in the form of a graph.*

FDA Label Image

Company Logo (Losartanpotassiumusp Figure 06)

FDA Label Image

Company Logo (Losartanpotassiumusp Figure 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.